Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8

Humans CD8-Positive T-Lymphocytes Memory T Cells Mitophagy Parkinson Disease COVID-19 Cell Death

Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
29 09 2023
Historique:
medline: 25 9 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: ppublish

Résumé

Mitophagy, a central process guarding mitochondrial quality, is commonly impaired in human diseases such as Parkinson's disease, but its impact in adaptive immunity remains unclear. The differentiation and survival of memory CD8

Identifiants

DOI: 10.1126/sciimmunol.adf7579 PMID: 37738363
pubmed: 37738363
doi: 10.1126/sciimmunol.adf7579
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadf7579

Auteurs

Fabien Franco (F)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0001-6312-7840

Alessio Bevilacqua (A)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0001-7009-4362

Ruey-Mei Wu (RM)

Neurology Department, National Taiwan University Hospital, Taipei, Taiwan.

Kung-Chi Kao (KC)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0002-5756-6684

Chun-Pu Lin (CP)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0001-5874-8001

Lorène Rousseau (L)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0009-0004-4135-0258

Fu-Ti Peng (FT)

Neurology Department, National Taiwan University Hospital, Taipei, Taiwan.

Yu-Ming Chuang (YM)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.

Jhan-Jie Peng (JJ)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
Center for Molecular and Clinical Immunology, Chang Gung University, Taoyuan City, Taiwan.
ORCID: 0000-0001-8923-9234

Jaeoh Park (J)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0003-2699-371X

Yingxi Xu (Y)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0002-0056-7440

Antonino Cassotta (A)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
ORCID: 0000-0001-8674-4294

Yi-Ru Yu (YR)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0002-3562-3502

Daniel E Speiser (DE)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.

Federica Sallusto (F)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Institute of Microbiology, ETH Zürich, Zürich, Switzerland.
ORCID: 0000-0003-3750-2752

Ping-Chih Ho (PC)

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
ORCID: 0000-0003-3078-3774

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Regulatory circuits of mitophagy restrict...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › Regulatory circuits of mitophagy restrict...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Cellules T mémoire › Regulatory circuits of mitophagy restrict...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Renouvellement des mitochondries › Dégradation des mitochondries › Regulatory circuits of mitophagy restrict...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Regulatory circuits of mitophagy restrict...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Regulatory circuits of mitophagy restrict...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Mort cellulaire › Regulatory circuits of mitophagy restrict...